Q1FY18 Result : Alembic Pharmaceuticals
DSIJ Intelligence / 20 Jul 2017
The company's total sales for Q1FY18 came in at Rs 648.2 crore, which represents a 12.6 per cent sequential decline and 12 per cent YoY decline.
Alembic Pharma reported its results for the quarter ended June 30, 2017 on Thursday.
The company's total sales for Q1FY18 came in at Rs 648.2 crore, which represents a 12.6 per cent sequential decline and 12 per cent YoY decline.
Its operating profit (EBIT) for the quarter amounted to Rs 79.6 crore and its EBIT margin stood at 12.3 per cent.
The company reported PAT of Rs 63.4 crore, which represents a sequential QoQ decline of 33.5 per cent and a YoY decline of 38.8 per cent.
Alembic Pharmaceuticals is an integrated research and development pharmaceutical company. It is one of the leaders in branded generics in India.
The company's stock opened at Rs 551.1 and touched intra-day high and low of Rs 573.5 and Rs 539.9, respectively, on the BSE.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.